Patent Number: 8,871,221

Title: Methods of stimulating protective immunity employing Dengue viral antigens

Abstract: Compositions that include at least a portion of at least one pathogen-associated molecular pattern and at least a portion of at least one member selected from the group consisting of a Den1 viral envelope protein, a Den2 viral envelope protein, a Den3 viral envelope protein and a Den4 viral envelope protein are employed in methods to stimulate a protective immune response in a subject.

Inventors: Powell; Thomas J. (Cranbury, NJ), Nakaar; Valerian (Cranbury, NJ), Song; Langzhou (Cranbury, NJ), Huleatt; James W. (Cranbury, NJ), McDonald; William F. (Cranbury, NJ), Hewitt; Duane D. (Hamilton, CA)

Assignee: Vaxinnate Corporation

International Classification: A61K 39/295 (20060101)

Expiration Date: 2018-10-28 0:00:00